KalVista Pharmaceuticals, Inc.(KALV)
Biotechnology
Rare Disease / Orphan Drug
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | Yea Christopher CHIEF DEVELOPMENT OFFICER | Sale | -33,800 | -12.82%229,918 | $26.78 | $905,225 | View SEC filing | |
| 2026-05-27 | Audhya Paul K. CHIEF MEDICAL OFFICER | Sale | -2,239 | -1.01%220,475 | $26.78 | $59,955 | View SEC filing | |
| 2026-05-27 | Sweeny Nicole Chief Commercial Officer | Sale | -1,489 | -2.45%59,291 | $26.78 | $39,872 | View SEC filing | |
| 2026-05-27 | Yea Christopher CHIEF DEVELOPMENT OFFICER | Sale | -1,966 | -0.85%229,918 | $26.78 | $52,645 | View SEC filing | |
| 2026-05-26 | Audhya Paul K. CHIEF MEDICAL OFFICER | Sale | -2,685 | -1.19%222,714 | $26.78 | $71,916 | View SEC filing | |
| 2026-05-26 | Sweeny Nicole Chief Commercial Officer | Sale | -1,861 | -3.23%55,780 | $26.78 | $49,846 | View SEC filing | |
| 2026-05-26 | Piekos Brian Chief Financial Officer | Sale | -1,489 | -8.81%15,411 | $26.78 | $39,882 | View SEC filing | |
| 2026-05-26 | Yea Christopher CHIEF DEVELOPMENT OFFICER | Sale | -2,358 | -1.02%228,759 | $26.78 | $63,158 | View SEC filing | |
| 2026-05-26 | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | Sale | -10,926 | -1.26%854,263 | $26.78 | $292,646 | View SEC filing | |
| 2026-05-19 | Audhya Paul K. CHIEF MEDICAL OFFICER | Sale | -1,032 | -0.46%225,399 | $26.76 | $27,616 | View SEC filing | |
| 2026-05-19 | Yea Christopher CHIEF DEVELOPMENT OFFICER | Sale | -1,108 | -0.48%227,367 | $26.76 | $29,650 | View SEC filing | |
| 2026-05-19 | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | Sale | -1,129 | -0.13%865,189 | $26.76 | $30,212 | View SEC filing | |
| 2026-05-13 | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | Sale | -3,322 | -0.38%866,318 | $26.71 | $88,731 | View SEC filing | |
| 2026-04-20 | Audhya Paul K. CHIEF MEDICAL OFFICER | Sale | -2,686 | -1.17%226,431 | $20.22 | $54,301 | View SEC filing | |
| 2026-04-20 | Sweeny Nicole Chief Commercial Officer | Sale | -1,862 | -3.50%51,391 | $20.22 | $37,643 | View SEC filing | |
| 2026-04-20 | Piekos Brian Chief Financial Officer | Sale | -1,862 | -9.92%16,900 | $20.22 | $37,643 | View SEC filing | |
| 2026-04-20 | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | Sale | -9,550 | -1.09%869,640 | $20.22 | $193,066 | View SEC filing | |
| 2026-03-27 | Koh Bong Y 10% Owner | Sale | -214,631 | -4.05%5,089,354 | $17.20 | $3,691,148 | View SEC filing | |
| 2026-03-10 | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | Sale | -6,693 | -0.76%879,190 | $16.08 | $107,633 | View SEC filing | |
| 2026-02-24 | Audhya Paul K. CHIEF MEDICAL OFFICER | Sale | -5,354 | -2.28%229,117 | $15.57 | $83,345 | View SEC filing | |
| 2026-02-24 | Sweeny Nicole Chief Commercial Officer | Sale | -3,975 | -7.80%47,003 | $15.57 | $61,878 | View SEC filing | |
| 2026-02-24 | Piekos Brian Chief Financial Officer | Sale | -1,767 | -8.61%18,762 | $15.57 | $27,507 | View SEC filing | |
| 2026-02-24 | Yea Christopher CHIEF DEVELOPMENT OFFICER | Sale | -4,347 | -1.88%226,701 | $15.57 | $67,669 | View SEC filing | |
| 2026-02-24 | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | Sale | -10,034 | -1.12%885,883 | $15.57 | $156,197 | View SEC filing | |
| 2026-02-19 | Audhya Paul K. CHIEF MEDICAL OFFICER | Sale | -1,163 | -0.49%234,471 | $15.00 | $17,445 | View SEC filing |
1-25 of 223